Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 2
2008 3
2009 2
2010 2
2011 2
2012 5
2015 5
2016 7
2017 6
2018 9
2019 8
2020 4
2021 5
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou GA, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou NG, Panayiotides IG, Perisanidis C, Fernandez AI, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung TN, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm DL, Foukas PG, Psyrri A. Moutafi M, et al. Among authors: papaxoinis g. Cancer Res Commun. 2023 Aug 10;3(8):1514-1523. doi: 10.1158/2767-9764.CRC-23-0051. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37575280 Free PMC article. Clinical Trial.
Hereditary Diffuse Gastric Cancer: A 2022 Update.
Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Kole C, et al. Among authors: papaxoinis g. J Pers Med. 2022 Dec 8;12(12):2032. doi: 10.3390/jpm12122032. J Pers Med. 2022. PMID: 36556253 Free PMC article. Review.
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Kamposioras K, Papaxoinis G, Dawood M, Appleyard J, Collinson F, Lamarca A, Ahmad U, Hubner RA, Wright F, Pihlak R, Damyanova I, Razzaq B, Valle JW, McNamara MG, Anthoney A. Kamposioras K, et al. Among authors: papaxoinis g. Acta Oncol. 2022 May;61(5):583-590. doi: 10.1080/0284186X.2022.2053198. Epub 2022 Apr 7. Acta Oncol. 2022. PMID: 35392758
Immunotherapy for gastric cancer: a 2021 update.
Kole C, Charalampakis N, Tsakatikas S, Kouris NI, Papaxoinis G, Karamouzis MV, Koumarianou A, Schizas D. Kole C, et al. Among authors: papaxoinis g. Immunotherapy. 2022 Jan;14(1):41-64. doi: 10.2217/imt-2021-0103. Epub 2021 Nov 17. Immunotherapy. 2022. PMID: 34784774 Review.
Melanoma and Sarcoidosis in Patients Receiving or Not Antineoplastic Therapy.
Gouveris P, Zouki DN, Sarris EG, Kolilekas L, Tryfonopoulos D, Papaxoinis G, Demiri S. Gouveris P, et al. Among authors: papaxoinis g. Case Rep Oncol. 2021 Jul 1;14(2):1059-1065. doi: 10.1159/000516035. eCollection 2021 May-Aug. Case Rep Oncol. 2021. PMID: 34326742 Free PMC article.
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas E, Lampaki S, Koliou GA, Koumarianou A, Levva S, Vagionas A, Christopoulou A, Laloysis A, Psyrri A, Binas I, Mountzios G, Kentepozidis N, Kotsakis A, Saloustros E, Boutis A, Nikolaidi A, Fountzilas G, Georgoulias V, Chrysanthidis M, Kotteas E, Vo H, Tsiatas M, Res E, Linardou H, Daoussis D, Bompolaki I, Andreadou A, Papaxoinis G, Spyratos D, Gogas H, Syrigos KN, Bafaloukos D. Fountzilas E, et al. Among authors: papaxoinis g. Cancer Immunol Immunother. 2022 Feb;71(2):327-337. doi: 10.1007/s00262-021-02985-6. Epub 2021 Jun 23. Cancer Immunol Immunother. 2022. PMID: 34164709 Free PMC article.
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
Economopoulou P, Anastasiou M, Papaxoinis G, Spathas N, Spathis A, Oikonomopoulos N, Kotsantis I, Tsavaris O, Gkotzamanidou M, Gavrielatou N, Vagia E, Kyrodimos E, Gagari E, Giotakis E, Delides A, Psyrri A. Economopoulou P, et al. Among authors: papaxoinis g. Cancers (Basel). 2021 Jan 14;13(2):286. doi: 10.3390/cancers13020286. Cancers (Basel). 2021. PMID: 33466719 Free PMC article.
59 results